Chemocentryx reported $-40051000 in Operating Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4717M 357M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Amgen AMGN:US $ 2500M 196M
AstraZeneca AZN:LN 878M 1.17B
Bayer BAYN:GR 2.02B 1.49B
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Mirati Therapeutics MRTX:US $ -184.22M 12.86M
Novartis NOVN:VX 2.56B 671M
Takeda 4502:JP Y -1619M 118103M
Teva Pharmaceutical TEVA:IT 78M 545M